Cargando…
Serum Iba-1, GLUT5, and TSPO in Patients With Diabetic Retinopathy: New Biomarkers for Early Retinal Neurovascular Alterations? A Pilot Study
PURPOSE: This study explored the possibility of highlighting early retinal neurovascular alterations of diabetic retinopathy (DR) by monitoring in DR patients the serum levels of microglial biomarkers ionized calcium-binding adapter molecule 1 (Iba-1), glucose transporter 5 (GLUT5), and translocator...
Autores principales: | Trotta, Maria Consiglia, Gesualdo, Carlo, Petrillo, Francesco, Cavasso, Giancuomo, Corte, Alberto Della, D'Amico, Giovanbattista, Hermenean, Anca, Simonelli, Francesca, Rossi, Settimio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934554/ https://www.ncbi.nlm.nih.gov/pubmed/35285861 http://dx.doi.org/10.1167/tvst.11.3.16 |
Ejemplares similares
-
Resolution of Inflammation in Retinal Disorders: Briefly the State
por: Trotta, Maria Consiglia, et al.
Publicado: (2022) -
Inhibition of Galectins and the P2X7 Purinergic Receptor as a Therapeutic Approach in the Neurovascular Inflammation of Diabetic Retinopathy
por: Lepre, Caterina Claudia, et al.
Publicado: (2023) -
Effects of the Calix[4]arene Derivative Compound OTX008 on High Glucose-Stimulated ARPE-19 Cells: Focus on Galectin-1/TGF-β/EMT Pathway
por: Trotta, Maria Consiglia, et al.
Publicado: (2022) -
Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study
por: Gesualdo, Carlo, et al.
Publicado: (2021) -
Galectin 1—A Key Player between Tissue Repair and Fibrosis
por: Hermenean, Anca, et al.
Publicado: (2022)